The management of patients with longstanding ulcerative colitis is mainly based on surveillance for the development of precancerous changes (Riddell, 1984) . Several reports have shown a close association between dysplastic changes in tumour-distant flat mucosa and coexisting colorectal carcinoma in patients with total ulcerative colitis (Morson & Pang, 1967; Riddell & Morson, 1979; Rosenstock et al., 1985 , Ransohoff et al., 1985 . However, dysplasia alone seems to be an insufficient marker for the optimal identification of patients at increased cancer risk. Firstly, the interpretation of dysplasia is subjective, and thus prone to a substantial intraobserver and interobserver variation (Riddell et al., 1983; Melville et al., 1988; Dixon et al., 1988) . Secondly, as dysplastic lesions may be distributed focally, there is a problem of adequate sampling (Riddell, 1976; Riddell & Morson, 1979; Ransohoff et al., 1985) . Thirdly, patients have developed carcinomas without having dysplasia detected in advance or in the operative specimen (Riddell, 1976; Lennard-Jones et al., 1983) . Better and more objective markers of early malignant transformation in the colonic epithelium are therefore clearly needed.
Abnormal cellular DNA content is generally considered to be a marker of premalignancy (Barlogie et al., 1983) . Flow cytometric DNA analysis is a rapid, objective and reproducible method for the evaluation of cellular DNA aberrations. Aneuploid cell populations have previously been found by DNA flow cytometry in the colonic mucosa of patients with ulcerative colitis, both preceding and coexistent with colonic carcinomas. Diverging results have been reported, however, both with regard to the proportion of aneuploid carcinomas in patients with ulcerative colitis, as well as the relationship between dysplasia and aneuploidy in tumour-distant flat mucosa (Hammarberg et al., 1984 , L0fberg et al., 1987 , Melville et al., 1988 , Fischbach et al., 1990 ).
In the present study, we have analysed the DNA ploidy pattern in flat mucosa, and in primary and metastatic carcinomas from patients with longstanding ulcerative colitis.
We have evaluated the relationship between aneuploidy and dysplasia, and between aneuploidy and carcinoma, and compared the DNA ploidy pattern in primary and metastatic carcinomas. Based on the results from our DNA analysis, we have also discussed the DNA ploidy changes emerging during carcinogenesis in ulcerative colitis.
Patients, materials and methods

Patients
Ten patients with total ulcerative colitis for eight years or more were studied. Nine patients underwent proctocolectomy, and one patient hemicolectomy. Six patients had proctocolectomy done because of histologically verified carcinomas, and one of these patients had two carcinomas diagnosed preoperatively. Three additional carcinomas were found in the resected specimens from two of these patients (Table II) . Two patients had synchronous, and one patient had metachronous metastases (Table I) . Four patients were operated prophylactically due to dysplasia in biopsy samples and/or increased disease activity (Table I ). None of the latter patients had carcinoma diagnosed in the resected specimens. Clinicopathological information on the patients and their carcinomas are given in Table I. Tissue sampling Eighty-nine fresh tissue samples from colonic flat mucosa, polypoid lesions, macroscopically evident carcinomas, and metastases were collected from resected specimens (including one sample from the autopsy of patient no. 2) (Table II) . From the seven preoperatively recognised carcinomas, a median of three (range 1 to 5) tissue samples were taken. From flat mucosa (and from the three polypoid lesions in patient no. 1), tissue samples were collected from a median of six (range 3 to 11) random locations (Table II) . All three patients with disseminated disease had metastases analysed; patient no. 1 had one retroperitoneal metastasis collected during second-look surgery 24 months after proctocolectomy, patient no. 2 had retroperitoneal cancer spread diagnosed at the time of primary surgery, from which a sample was collected during autopsy 5 months later, and patient no. 6 had a liver metastasis collected peroperatively. (Dukes, 1932; Turnbull et al., 1967) . bAccording to the criteria given by WHO (Morson & Sobin, 1976 Histological grading of dysplasia The histological grading of epithelial dysplasia was done on hematoxylin-eosin stained sections adjacent to the samples processed for DNA flow cytometry, and performed independently by two pathologists. Whenever discrepancy existed in classification, a joint diagnosis was achieved. The mucosa samples were categorized into: no dysplasia, indefinite for dysplasia, low grade or high grade dysplasia, according to the latest standardised classification of dysplasia in inflammatory bowel disease (Riddell et al., 1983) .
DNA flow cytometry
Single cell suspensions were prepared immediately after surgery (in one instance immediately after autopsy). The tissue samples were minced in ice-cold phosphate-buffered saline (PBS), pH 7.6, followed by nylon mesh filtration (mesh pore size 70 pm) (Seidengazefabrik AG Thal, Switzerland four to ten were stained according to the method described by by Crissman & Steinkamp (1982) . The cells were incubated with RNAase (Boehring, Mannheim, Germany), 190 yg ml-' for 30 min in the dark at 20°C, and thereafter stained with the fluorochrome propidium iodide (Sigma Chemical Co., St.
Louis, MO, USA), 17 1tg ml-I for 1 h in the dark at 0°C. The analyses were done with an Ortho Cytofluorograph 50H (Ortho Instruments, Westwood, MA, USA).
Mouse spleen lymphocytes were used as an external diploid (2c) DNA control. The cellular amount of DNA was expressed as a DNA index (Hiddemann et al., 1984) . A tissue sample was defined as aneuploid when a second detectable population of GI cells was present with a DNA index > 1.10, otherwise the tissue sample was defined as diploid (or in samples from carcinomas, as near diploid).
Statistical analysis
For differences in distributions, the X2 test with Yates correction for small numbers was applied.
Results
DNA ploidy pattern in carcinomas and in tumour-distant flat mucosa Six of the ten carcinomas (60%) were aneuploid (Table II, and Figures 1 and 2) . The six aneuploid carcinomas were found in patients nos. 1, 2, 4, and 6. These four patients also had aneuploid cell populations in tumour-distant flat mucosa. Three of these four patients (patients nos. 2, 4, and 6) had the same DNA index in tumour-distant flat mucosa as in (one of) the carcinoma(s). Two patients (patients nos. 3 and 5), had near diploid carcinomas. Patient no. 5 had aneuploid cells in tumour-distant flat mucosa, whereas this was not found in patient no. 3. In the three patients with two or more carcinomas (patients nos. 1, 3, and 4) there was no consistent DNA ploidy pattern between the different carcinomas within the same patient (Table II, and Figures 1 and 2 ).
DNA ploidy pattern in flat mucosa from patients without carcinoma Twenty-nine mucosa samples were analysed from the four patients without carcinoma. Only two of these samples (from patient no. 9) were aneuploid, both with a DNA index of 1.7 (Table II) .
Relationship between DNA aneuploidy and dysplasia Five of the six carcinoma patients, and one of the four patients without carcinoma had DNA aneuploidy in flat mucosa (P>0.1) (Table II) . Epithelial dysplasia in flat mucosa was found in five of the six carcinoma patients, and three of the four patients without carcinoma (Table II) . High grade dysplasia was demonstrated in four of the six patients with carcinoma, and in one of the four patients without carcinoma.
From the six patients with carcinoma, 32 non-cancerous flat mucosa samples were analysed (Table II) . Eighteen samples (56%) showed dysplasia. Seven of the 18 dysplastic mucosa samples (39%) were aneuploid, compared with four of 14 non-dysplastic mucosa samples (29%) (n.s.). Two of the seven mucosa samples with high grade dysplasia (29%), and five of the 11 mucosa samples with low grade dysplasia (45%) were aneuploid, both compared with four of 14 nondysplastic mucosa samples (both n.s., respectively).
From the four non-carcinoma patients, a total of 29 mucosa samples were analysed. Eleven samples (38%) had dysplastic changes, but none of these showed aneuploid cell populations.
Of the total of 61 non-cancerous flat mucosa samples, seven of 29 dysplastic mucosa samples (24%) were aneuploid, compared with six of 32 non-dysplastic mucosa samples (18%) (n.s.). Two of nine mucosa samples with high grade dysplasia (22%), and five of 20 mucosa samples with low grade dysplasia (25%) were aneuploid, both compared with six of the 32 non-dysplastic mucosa samples (both n.s., respectively).
DNA ploidy pattern in primary and metastatic carcinoma The six patients with carcinomas were followed postoperatively for 26 months or more (Table I) . The three patients with metastases all had aneuploid cell populations with the same or similar DNA indices in the primary carcinoma as in the metastatic lesions (Table II, Figure 3 ).
Discussion
The colonoscopic surveillance for premalignancy in patients with ulcerative colitis is currently based on screening for dysplastic changes in biopsy samples at repeated examinations (Riddell, 1984) . The grading of dysplasia, however, is highly subjective (Riddell et al., 1983; Melville et al., 1988; Dixon et al., 1988) , and is further complicated if severe inflammation is present (Riddell, 1976; 1983) . Among other markers of premalignancy (Rognum et al., 1987a) DNA aneuploidy reflecting abnormal chromosome content within cell nuclei, has become the one of greatest interest.
In the present study, aneuploid cell populations could be demonstrated in six of ten colonic carcinomas from patients with ulcerative colitis. We have earlier reported similar proportions of aneuploidy in colorectal carcinomas from larger series of patients without ulcerative colitis (Rognum et al., 1982; 1987b; Meling et al., 1991) . Other studies have also reported similar proportions of aneuploid carcinomas in patients with ulcerative colitis (Hammarberg et al., 1984; Melville et al., 1988) . In one study, however, a much lower proportion of aneuploid carcinomas in ulcerative colitis was found , but a small number of samples analysed from each carcinoma might perhaps explain the low rate of aneuploidy detected (Rognum et al., 1980; Fozard et al., 1987; Melville et al., 1987) .
In the six patients with carcinoma, high grade dysplasia was present only in four. This indicates that high grade dysplasia is not sufficient as marker for malignant development. Dysplasia and DNA aneuploidy are different markers of malignant cell transformation. The relationship between them, however, is still not settled. Some studies have demonstrated a significant association between the two markers (Hammarberg et al., 1984; Melville et al., 1988) , whereas in other reports, no relationship was found Fischbach et al., 1990) . In the present study, we could demonstrate no significant association between DNA ploidy pattern and dysplasia. A part of this discrepancy may be due to the fact that the assessment of dysplasia is highly subjective compared with the more objective evaluation of DNA ploidy one aneuploid cell population with DNA index of 1.5. In these DNA analysis, both an old sample from the main carcinoma and the freshly removed metastasis were analysed according to the method of Crissman & Steinkamp (1982) .
pattern (Melville et al., 1988) . However, our results suggest that in patients with ulcerative colitis, aneuploidy and dysplasia occur independently in the individual mucosa samples. A close association has earlier been demonstrated between the presence of carcinoma and aneuploidy in tumour-distant flat mucosa (Hammarberg et al., 1984; Melville et al., 1988) . In our study, DNA aneuploidy was found in tumour-distant flat mucosa in five of six patients with carcinoma, and in one of four patients without carcinoma (this patient being the one with high grade dysplasia among the non-carcinoma patients). This indicates that DNA aneuploidy is associated with malignant transformation in the large bowel, but larger series is needed to evaluate the specificity of aneuploidy for cancer development in ulcerative colitis mucosa. However, since approximately one out of three large bowel carcinomas are near diploid, the absence of aneuploidy in flat mucosa does not exclude malignant transformation elsewhere in the mucosa. We could, however, demonstrate that aneuploid cell populations in tumour-distant flat mucosa were not restricted to the patients with aneuploid carcinomas, since two of the three patients with (microscopically evident) near diploid carcinomas, had aneuploid cell populations in tumour-distant flat mucosa (Figure 2) .
In aneuploid adenomas, another premalignant lesion in the colonic mucosa, a high percentage of DNA indices between 0.80 and 1.20 has been reported (van den Ingh et al., 1985; Giaretti et al., 1988; Giaretti & Santi, 1990) , although DNA indices similar to those of adenocarcinomas have also been reported . This low ploidy alteration was suggested to reflect early steps in the aneuploid transformation in the carcinogenesis of colorectal adenomas. In our study, however, the high proportion of aneuploid cell clones with a DNA index of 1.7 (present in nine of 14 aneuploid mucosa samples) (Figure 2) indicates that this ploidy change may be associated with early aneuploid malignancy in ulcer- ative colitis. The process of carcinogenesis may therefore be different in adenomas and in ulcerative colitis mucosa. This is further supported by a recent study of c-Ki-ras mutations, reporting different genetic pathways for tumour progression in colonic mucosa with and without ulcerative colitis (Burmer et al., 1990) . A combination of flow cytometric and genetic analyses addressing this question are already in progress in our laboratory.
Five patients had aneuploid carcinomas. Three of them also had aneuploid cell clones in tumour-distant flat mucosa, and these three were the only patients with metastatic disease (Table II) . This is, however, interesting, since aneuploid carcinomas are associated with a worse prognosis than diploid ones (Wolley et al., 1982; Armitage et al., 1985; Rognum et al., 1987b; . The aneuploid cells in the mucosa from these three patients, all had DNA indices different from 1.7, and in two of the patients, the DNA index was the same as in the main carcinoma. Furthermore, the DNA indices found in the primary carcinomas of these three patients, were also demonstrated in the metastatic carcinomas, respectively (Rognum et al., 1985) . The aneuploid cells found in the mucosa of these patients may therefore have reached a point in the carcinogenesis where the ploidy changes are preserved in the cell population that grow invasively, and subsequently establish distant organ metastases.
Within single patients, we frequently observed aneuploid cell populations from separate mucosa samples with similar DNA indices, (Table II, Figure 2 ) as has also been reported by others , Rutegard et al., 1989 . We also found the same DNA index in cells from mucosa-and carcinoma samples within single patients. This individual preference of certain ploidy changes might be the result of evenly distributed carcinogenic factors in the colonic mucosa. Furthermore, the genetic constitution of the patient is also likely to influence the ploidy changes (Hsu, 1983) . Aneuploid cell clones with identical DNA indices have previously been reported in synchronous carcinomas, supposed to reflect a transluminal metastatic spread from a single lesion (Schwartz et al., 1986) . A transluminal spread is, however, highly unlikely in our ulcerative colitis patients, since we found similar DNA indices in separate premalignant lesions (which do not have the potential to metastasise), and also in both premalignant and malignant lesions.
Our results show that aneuploidy occurring in flat mucosa of patients with ulcerative colitis is not confined to dysplastic epithelium. DNA flow cytometric analysis may therefore contribute, together with other markers (Rognum et al., 1987a) , to the identification of the subset of patients with increased cancer risk, and who might therefore benefit from a closer surveillance. Larger series of patients is however needed to evaluate the specificity of aneuploidy occurring in ulcerative colitis mucosa.
